EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analysis of low-density lipoprotein receptor gene mutations in a family with familial hypercholesterolemia

Ya-Nan Hu, Min Wu, Hong-Ping Yu, Qiu-Yan Wu, Ying Chen, Jian-Hui Zhang, Dan-Dan Ruan, Yan-Ping Zhang, Jing Zou, Li Zhang, Xin-Fu Lin, Zhu-Ting Fang und 4 weitere

PLOS ONE · 11.10.2024 · 19 (10) · e0310547

DOI: 10.1371/journal.pone.0310547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 11.10.2024. Verfasst von Ya-Nan Hu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Receptors, LDL, Hyperlipoproteinemia Type II, Pedigree, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Province Natural Science Fund Project, Fujian Provincial Youth Scientific Program on health, Fujian Province Medical Innovation Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Familial hypercholesterolemia (FH) is a common monogenic autosomal dominant disorder, primarily mainly caused by pathogenic mutations in the low-density lipoprotein receptor (LDLR) gene. Through phenotypic-genetic linkage analysis, two LDLR pathogenic mutations were identified in FH families: c.G1027A (p.Gly343Ser) and c.G1879A (p.Ala627Thr). Materials and methods Whole exome sequencing was conducted on the proband with familial hypercholesterolemia to identify the target gene and screen for potential pathogenic mutations. The suspicious responsible mutation sites in 14 family members were analyzed using Sanger sequencing to assess genotype-phenotype correlations. Mutant and wild type plasmids were constructed and transfected into HEK293T cells to evaluate LDLR mRNA and protein expression. In parallel, bioinformatics tools were employed to predict structural and functional changes in the mutant LDLR.

Results

Immunofluorescence analysis revealed no significant difference in the intracellular localization of the p.Gly343Ser mutation, whereas protein expression of the p.Ala627Thr mutation was decreased and predominantly localized in the cytoplasm. Western blotting has showed that protein expression levels of the mutant variants were markedly declined in both cell lysates and supernatants. Enzyme linked immunosorbent assay has demonstrated that LDLR protein levels in the supernatant of cell culture medium was not significant different from those of the wild-type group. However, LDLR protein levels in the cell lysate of both the Gly343Ser and Ala627Thr variants groups were significantly lower than those in the wild-type group. Bioinformatic predictions further suggested that these mutations may affect post-translational modifications of the protein, providing additional insight into the mechanisms underlying the observed reduction in protein expression.

Conclusions

In this study, we identified two heterozygous pathogenic variants in the LDLR gene, c.G1027A (p.Gly343Ser) and c.G1879A (p.Ala627Thr), in a family with familial hypercholesterolemia. We also conducted preliminary investigations into the mechanisms by which these mutations contribute to disease pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, LDLHyperlipoproteinemia Type IIPedigreeMutationHumansFemaleMaleHEK293 CellsAdultMiddle AgedExome Sequencing

Substanzen

Receptors, LDLLDLR protein, human

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.
  • Department of Traditional Chinese Medicine, Fujian Provincial Hospital, Fuzhou, China.
  • Department of Nephrology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
  • Pediatrics department, Fujian Provincial Hospital, Fuzhou, China.
  • Department of Oncology and Vascular Intervention, Fujian Provincial Hospital, Fuzhou, China.
  • Department of Hematology, Fujian Provincial Hospital, Fuzhou, China.

ORCID-Profile: Jie-Wei Luo

Förderung

  • Fujian Province Natural Science Fund Project
  • Fujian Provincial Youth Scientific Program on health
  • Fujian Province Medical Innovation Foundation
  • Special Research Foundation of Fujian Provincial Department of Finance
  • National famous and old Chinese

Zitieren

APA

Hu, Y. N., Wu, M., Yu, H. P., Wu, Q. Y., Chen, Y., Zhang, J. H., Ruan, D. D., Zhang, Y. P., Zou, J., Zhang, L., Lin, X. F., Fang, Z. T., Liao, L. S., Lin, F., Li, H., & Luo, J. W. (2024). Analysis of low-density lipoprotein receptor gene mutations in a family with familial hypercholesterolemia. PLOS ONE, 19(10), e0310547. https://doi.org/10.1371/journal.pone.0310547

Vancouver

Hu YN, Wu M, Yu HP, Wu QY, Chen Y, Zhang JH, et al. Analysis of low-density lipoprotein receptor gene mutations in a family with familial hypercholesterolemia. PLOS ONE. 2024;19(10):e0310547. doi:10.1371/journal.pone.0310547

BibTeX
@article{Hu2024,
  author = {Hu, Ya-Nan and Wu, Min and Yu, Hong-Ping and Wu, Qiu-Yan and Chen, Ying and Zhang, Jian-Hui and Ruan, Dan-Dan and Zhang, Yan-Ping and Zou, Jing and Zhang, Li and Lin, Xin-Fu and Fang, Zhu-Ting and Liao, Li-Sheng and Lin, Fan and Li, Hong and Luo, Jie-Wei},
  title = {Analysis of low-density lipoprotein receptor gene mutations in a family with familial hypercholesterolemia},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {10},
  pages = {e0310547},
  doi = {10.1371/journal.pone.0310547}
}
Kostenlos starten →